The Company's focuses on using proprietary taste receptor-based assays, screening technologies and optimization chemistry to discover and develop novel flavors, flavor enhancers and taste modulators for the packaged food and beverage industry.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
In addition to the obvious positive fundamentals of the business (health movement, strong partners), here are 3 more reasons to like SNMX right now:
1.) Legendary high-growth investor John Laporte owns $21.0 million worth in his T. Rowe Price New Horizons fund and T. Rowe Price holds $75 million in total between its institutional and mutual fund holdings representing 23% of the company.
2. ) With its first commercial product finally expected to hit shelves in a matter of months, I'm betting the summer will be kind to SNMX.
3.) At $12 bucks and change the stock is trading near the bottom of it's 2 year range of $12 - $20.
Legendary John Laporte? A google search doesn't even bring him up.